Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAsa Resources Regulatory News (ASA)

  • There is currently no data for ASA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Asa Resource Group plc

26 Jul 2017 10:39

RNS Number : 1450M
ASA Resource Group PLC
26 July 2017
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Asa Resource Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/a

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Asa Resource Group plc

(d) Is the discloser the offeror or the offeree?

Offeree

(e) Date position held:

The latest practicable date prior to the disclosure

25 July 2017

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary Shares of 0.1 pence each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

-

NIL

-

(2) Cash-settled derivatives:

 

NIL

-

NIL

-

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

-

NIL

-

 

TOTAL:

NIL

-

NIL

-

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

None

Details, including nature of the rights concerned and relevant percentages:

None

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

3(a) Interests of directors of Asa Resource Group plc in ordinary shares of Asa Resource Group plc

 

Director

Number of ordinary shares

Percentage of total voting rights (%) (to 2d.p.)

Ian Barry Dearing

4,645,967

0.27%

Dr Scott Morrison

6,283,516

0.37%

Niall Henry

29,070,091

1.72%

 

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

26 July 2017

Contact name:

Barry Dearing

Telephone number:

+44 (0)7803 583 048 (UK)

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEEFMGZNLVNGNZG
Date   Source Headline
26th May 201712:31 pmRNSHolding(s) in Company
19th May 20177:00 amRNSOperations and Explorations Q4 Update
2nd May 201711:22 amRNSBoard and management structure update
2nd May 20177:00 amRNSBoard appointment
26th Apr 20178:31 amRNSHolding(s) in Company
26th Apr 20177:00 amRNSPress coverage
26th Apr 20177:00 amRNSNew website
21st Apr 201710:13 amRNSHolding(s) in Company
20th Apr 20177:00 amRNSDirector Dealing
19th Apr 20177:12 amRNSAnonymous allegations, Legal update, Freda Rebecca
18th Apr 20179:13 amRNSAnonymous allegations, Legal update, Freda Rebecca
4th Apr 20177:00 amRNSAnonymous allegations: Freda Rebecca
31st Mar 20177:00 amRNSTotal Voting Rights
28th Mar 201711:05 amRNSSecond Price Monitoring Extn
28th Mar 201711:00 amRNSPrice Monitoring Extension
22nd Mar 20174:10 pmRNSExercise of options
22nd Mar 201711:02 amRNSHolding(s) in Company
17th Feb 20177:00 amRNSOperations and Explorations Q3 Update
13th Feb 20172:54 pmRNSHolding(s) in Company
7th Feb 20177:00 amRNSExport incentive scheme & Top producer award
24th Jan 201712:50 pmRNSREPLACEMENT: Holding(s) in Company
24th Jan 20177:00 amRNSLegal update - Zindico Consortium
23rd Jan 20173:27 pmRNSHolding(s) in Company
12th Jan 20177:00 amRNSUpdate alleged lawsuit - Zindico Consortium
5th Jan 20171:12 pmRNSAlleged lawsuit - Zindico Consortium
19th Dec 20167:00 amRNSInterim Results and Operational Update
14th Dec 20167:00 amRNSManagement changes
7th Dec 20169:06 amRNSSecond Price Monitoring Extn
7th Dec 20169:00 amRNSPrice Monitoring Extension
30th Nov 20167:00 amRNSTotal Voting Rights
28th Nov 20161:00 pmRNSBNC - Release of Interim Financial Results
7th Nov 20167:00 amRNSOperations and Explorations Update for Q2
2nd Nov 201610:23 amRNSExercise of options
19th Oct 20163:10 pmRNSSub-division of share capital
29th Sep 201612:08 pmRNSTrading update, Co Sec& dealing - replacement
29th Sep 20167:00 amRNSTrading update, Co Sec & Director dealing
27th Sep 20163:37 pmRNSResult of AGM
27th Sep 201611:25 amRNSBoard Changes
23rd Sep 20168:45 amRNSTrading Update
8th Sep 20164:40 pmRNSSecond Price Monitoring Extn
8th Sep 20164:35 pmRNSPrice Monitoring Extension
6th Sep 20164:40 pmRNSSecond Price Monitoring Extn
6th Sep 20164:35 pmRNSPrice Monitoring Extension
22nd Aug 20167:00 amRNSAppointment of non-executive director
22nd Aug 20167:00 amRNSNotice of AGM and Distribution of Annual Report
11th Aug 20167:00 amRNSQuarterly Operations and Explorations Update
19th Jul 20161:04 pmRNSAnnual Financial Report
8th Jul 201610:49 amRNSFull Year Financial Results Release Date
6th Jul 201612:05 pmRNSHolding(s) in Company
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.